Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-28

Clinical Trial Update: TRISCEND JAPAN Study [NA]

View source ↗

Summary

The TRISCEND JAPAN study by Edwards Lifesciences is currently active but not recruiting. The study concerns tricuspid valve regurgitation and related heart valv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Edwards Lifesciences | Conditions: Tricuspid Valve Regurgitation, Heart Valve Diseases | NA | Status: ACTIVE_NOT_RECRUITING